ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology

Clinical Nutrition

Volumn 25, Issue 2, 2006, Pages 245-259

  Arends, J ^a   Bodoky, G ^b   Bozzetti, F ^c   Fearon, K ^d   Muscaritoli, M ^e   Selga, G ^f   van Bokhorst de van der Schueren, M A E ^g   von Meyenfeldt, M ^h   Zurcher G ^b   Fietkau, R ^b   Aulbert, E ^b   Frick, B ^b   Holm, M ^b   Kneba, M ^b   Mestrom, H J ^b   Zander, A ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Szent László Kórház ^*

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f Latvian Centre of Oncology   (Latvia)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cachexia; Chemotherapy; Clinical practice; Enteral nutrition; Evidence based; Guideline; Hematopoietic stem cell transplantation; Malnutrition; Oncology; Oral nutritional supplements; Radiotherapy; Tube feeding; Undernutrition; Wasting

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; ARGININE; DOCOSAHEXAENOIC ACID; FISH OIL; GESTAGEN; GLUTAMINE; ICOSAPENTAENOIC ACID; MEGESTROL ACETATE; OMEGA 3 FATTY ACID; PLACEBO; STEROID;

ABDOMINAL SURGERY; ANOREXIA; ARTICLE; CACHEXIA; CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM CANCER; DRUG EFFICACY; DRUG MEGADOSE; ENERGY EXPENDITURE; ENTERIC FEEDING; EVIDENCE BASED MEDICINE; FLUID RETENTION; HEAD AND NECK CANCER; HUMAN; MALNUTRITION; META ANALYSIS; MUCOSA INFLAMMATION; NEUTROPENIA; NUTRITIONAL COUNSELING; NUTRITIONAL STATUS; PRACTICE GUIDELINE; PROGNOSIS; QUALITY OF LIFE; SIDE EFFECT; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; THROMBOSIS; TREATMENT INDICATION; TUBE FEEDING; WEIGHT REDUCTION;

CACHEXIA; ENTERAL NUTRITION; EUROPE; HUMANS; MALNUTRITION; MEDICAL ONCOLOGY; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 33744513119     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2006.01.020     Document Type: Article

References (146)

1. Moldawer L.L., and Copeland E.M. Proinflammatory cytokines, nutritional support, and the cachexia syndrom. Cancer 79 (1997) 1828-1839
2. de Blaauw I., Deutz N.E.P., and von Meyenfeldt M.F. Metabolic changes of cancer cachexia-second of two parts. Clin Nutr 16 (1997) 223-228
3. de Blaauw I., Deutz N.E.P., and von Meyenfeldt M.F. Metabolic changes in cancer cachexia-first of two parts. Clin Nutr 16 (1997) 169-176
4. Barber M.D. The pathophysiology and treatment of cancer cachexia. Nutr Clin Pract 17 (2002) 203-209
5. Tisdale M.J. Protein loss in cancer cachexia. Science 289 (2000) 2293
6. Tisdale M.J. Cachexia in cancer patients. Nat Rev Cancer 2 11 (2002) 862-871
7. Inui A. Cancer anorexia-cachexia syndrome: are neuropeptides the key?. Cancer Res 59 (1999) 4493-4501
8. von Meyenfeldt M.F. Nutritional support during treatment of biliopancreatic malignancy. Ann Oncol 10 Suppl. 4 (1999) 273-277
9. Fearon K.C.H., Barber M.D., Falconer J.S., McMillan D.C., Ross J.A., and Preston T. Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia. World J Surg 23 (1999) 584-588
10. Fordy C, Glover C, Henderson DC, Summerbell C, Wharton R, Allen-Mersh TG. Contribution of diet, tumour volume and patient-related factors to weight loss in patients with colorectal liver metastases. Br J Surg 1999; 639-44.
11. Simons J.P.F.H.A., Schols A.M., Buurman W.A., and Wouters E.F. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci 97 (1999) 215-223
12. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 9255 (2001) 539-545
13. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 6917 (2002) 860-867
14. Espat N.J., Moldawer L.L., and Copeland E.M. Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients. J Surg Oncol 58 (1995) 77-82
15. Martin F., Santolaria F., Batista N., et al. Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine 11 1 (1999) 80-86
16. O'Gorman P., McMillan D.C., and McArdle C.S. Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer 37 1 (2000) 36-40
17. Jamieson NB, Glen P, McMillan DC, et al. Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer 2004.
18. Lundholm K., Holm G., and Schersten T. Insulin resistance in patients with cancer. Cancer Res 38 12 (1978) 4665-4670
19. Starnes H.F., Warren R.S., and Brennan M.F. Protein synthesis in hepatocytes isolated from patients with gastrointestinal malignancy. J Clin Invest 80 (2002) 1384-1390
20. Shaw J.H.F., and Wolfe R.R. Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. Ann Surg 205 (1997) 368-376
21. Zuijdgeest-van Leeuwen S.D., van den Berg J.W.O., Wattimena J.L.D., et al. Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects. Metabolism 49 7 (2000) 931-936
22. Körber J., Pricelius S., Heidrich M., and Müller M.J. Increased lipid utilization in weight losing and weight stable cancer patients with normal body weight. Eur J Clin Nutr 53 (1999) 740-745
23. Barber M.D., McMillan D.C., Preston T., Ross J.A., and Fearon K.C.H. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supllement. Clin Sci 98 4 (2000) 389-399
24. Legaspi A., Jeevanandam M., Starnes Jr. H.F., and Brennan M.F. Whole body lipid and energy metabolism in the cancer patient. Metabolism 36 10 (1987) 958-963
25. Cabal-Manzano R., Bhargava P., Torres-Duarte A., Marshall J., Bhargava P., and Wainer I.W. Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss. Br J Cancer 84 12 (2001) 1599-1601
26. Jeevanandam M., Horowitz G.D., Lowry S.F., and Brennan M.F. Cancer cachexia and protein metabolism. Lancet 1 (1984) 1424-1426
27. Williams A., Sun X., Fischer J.F., and Hasselgren P.O. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery 126 (1999) 744-750
28. Bossola M., Muscaritoli M., Costelli P., et al. Increased muscle ubiquitin mRNA levels in gastric cancer patients. Am J Physiol Regulatory Integrative Comp Phsyiol 280 (2001) R1518-R1523
29. Muscaritoli M., Bossola M., Bellantone R., and Rossi F.F. Therapy of muscle wasting in cancer: what is the future?. Curr Opin Clin Nutr Metab Care 7 4 (2004) 459-466
30. DeWys W.D., Begg C., Lavin P.T., et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69 (1980) 491-497
31. Chute C.G., Greenberg E.R., Baron J., Korson R., Baker J., and Yates J. Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont. Cancer 56 (1985) 2107-2111
32. Wigmore S.J., Plester C.E., Richardson R.A., and Fearon K.C.H. Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75 1 (1997) 106-109
33. Andreyev H.J.N., Norman A.R., Oates J., and Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer 34 4 (1998) 503-509
34. Bozzetti F., Migliavacca S., Scotti A., et al. Impact of cancer, type, site, stage and treatment on the nutritional status of patients. Ann Surg 196 2 (1982) 170-179
35. Costa G., and Donaldson S.S. Current concepts in cancer. N Engl J Med 300 26 (1979) 1471-1473
36. McAnena O.J., and Daly J.M. Impact of antitumor therapy on nutrition. Surg Clin North Am 66 6 (1986) 1213-1228
37. van Eys J. Effect of nutritional status on response to therapy. Cancer Res 42 Suppl. (1982) 747-753
38. Ollenschläger G., Thomas W., Konkol K., Diehl V., and Roth E. Nutritional behaviour and quality of life during oncological polychemotherapy: results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukaemia. Eur J Clin Invest 22 8 (1992) 5-23
39. Tubiana M., Attié E., Flamant R., Gérard-Marchant R., and Hayat M. Prognostic factors in 454 cases of Hodgkin's disease. Cancer Res 31 (1971) 1801-1810
40. Swenerton K.D., Legha S.S., Smith T., et al. Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 39 (1979) 1552-1562
41. Pedersen H., Hansen H.S., Cederqvist C., and Lober J. The prognostic significance of weight loss and its integration in stage-grouping of oesophageal cancer. Acta Chir Scand 148 (1982) 363-366
42. Fein R., Kelsen D.P., Geller N., Bains M., McCormack P., and Brennan M.F. Adenocarcinoma of the esophagus and gastroesophageal junction. Cancer 56 (1985) 2512-2518
43. van Bokhorst-de van der Schueren M.A.E., van Leeuwen P.A.M., Kuik D.J., et al. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 86 (1999) 519-527
44. Klastersky J., Daneau D., and Verhest A. Causes of death in patients with cancer. Eur J Cancer 8 2 (1972) 149-154
45. Inagaki J., Rodriguez V., and Bodey G.P. Proceedings: causes of death in cancer patients. Cancer 33 2 (1974) 568-573
46. Ambrus J.L., Ambrus C.M., Mink I.B., and Pickren J.W. Causes of death in cancer patients. J Med 6 1 (1975) 61-64
47. Warren S. The immediate causes of death in cancer. Am J Med Sci 184 (1932) 610-615
48. Aslani A., Smith R.C., Allen B.J., Paviakis N., and Levi J.A. The predictive value of body protein for chemotherapy-induced toxicity. Cancer 88 (2000) 796-803
49. Knox L.S., Crosby L.O., Feurer I.D., Buzby G.P., Miller C.L., and Mullen J.L. Energy expenditure in malnourished cancer patients. Ann Surg 197 2 (1983) 152-161
50. Dempsey D.T., Feurer I.D., Knox L.S., Crosby L.O., Buzby G.P., and Mullen J.L. Energy expenditure in malnourished gastrointestinal cancer patients. Cancer 53 (1984) 1265-1273
51. Dempsey D.T., Knox L.S., Mullen J.L., Miller C.L., Feurer I.D., and Buzby G.P. Energy expenditure in malnourished patients with colorectal cancer. Arch Surg 121 7 (1986) 789-795
52. Hansell D.T., Davies J.W., and Burns H.J. Effects of hepatic metastases on resting energy expenditure in patients with colorectal cancer. Br J Surg 73 8 (1986) 659-662
53. Fredrix E.W., Soeters P.B., Wouters E.F., Deerenberg I.M., von Meyenfeldt M.F., and Saris W.H. Effect of different tumor types on resting energy expenditure. Cancer Res 51 (1991) 6138-6141
54. Moses A.W., Slater C., Preston T., Barber M.D., and Fearon K.C. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90 5 (2004) 996-1002
55. Gibney E., Elia M., Jebb S.A., Murgatroyd P., and Jennings G. Total energy expenditure in patients with small-cell lung cancer: results of a validated study using the bicarbonate-urea method. Metabolism 46 12 (1997) 1412-1417
56. Staal-van den Brekel A.J., Dentener M.A., Schols A.M., Buurman W.A., and Wouters E.F. Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol 13 10 (1995) 2600-2605
57. Harris JA, Benedict FG. Standard basal metabolism constants for physiologists and clinicians. In: Carnegie Institute of Washington Publication, editor. A biometric study of basal metabolism in man. Philadelphia: Lippincott, 1919. p. 223-50.
58. Schofield W.N. Predicting basal metabolic rate, new standards and review of previous work. Clin Nutr 39 Suppl. 1 (1985) 5-41
59. Joint FAO/WHO/UNU Expert Consultation. Energy and protein requirements. WHO Technical Report Series 724. Geneva: World Health Organization; 2005.
60. Staal-van den Brekel A.J., Schols A.M., Dentener M.A., Ten Velde G.P., Buurman W.A., and Wouters E.F. The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma. Br J Cancer 76 12 (1997) 1630-1635
61. Nitenberg G., and Raynard B. Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 34 3 (2000) 137-168
62. Barrera R. Nutritional support in cancer patients. J Parenter Enteral Nutr 26 5 Suppl. (2002) S63-S71
63. Howard L., Ament M., Fleming C.R., Shike M., and Steiger E. Current use and clinical outcome of home parenteral and Enteral Nutrition therapies in the United States. Gastroenterology 109 (1995) 355-365
64. ASPEN Board of Directors, Clinical Guidelines Task Force. Normal requirements-adults. J Parenter Enteral Nutr 26 1 (2002) 22SA-23SA
65. Mantovani G., Maccio A., Madeddu C., et al. Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress. J Mol Med 81 10 (2003) 664-673
66. Gogos C.A., Ginopoulos P., Salsa B., Apostolidou E., Zoumbos N.C., and Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy. Cancer 82 (1998) 395-402
67. Ravasco P., Monteiro-Grillo I., Vidal P.M., and Camilo M.E. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 23 7 (2005) 1431-1438
68. Daly J.M., Weintraub F.N., Shou J., Rosato E.F., and Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 221 4 (1995) 327-338
69. Arnold C., and Richter M.P. The effect of oral nutritional supplements on head and neck cancer. Int J Radiat Oncol Biol Phys 16 6 (1989) 1595-1599
70. Hackl J.M., and Balogh D. Indikation zur künstlichen Ernährung-was ist gesichert?. Akt Ernährungsmed 22 (1997) 146-153
71. Druml W., Jadrna K., and Roth E. Empfehlungen fuer die parenterale und enterale Ernaehrung des Erwachsenen. 3rd ed (2004), Arbeitsgemeinschaft Klinische Ernährung (AKE), Vienna
72. van Hoof P., Buill-Haasen M., Rouflart N., Soeters P.B., and von Meyenfeldt M.F. Anorexia, malnutrition and food aversion with newly detected gastric or colorectal cancer. Clin Nutr 8 (1989) 151
73. Anonymous. American Gastroenterological Association medical position statement: parenteral nutrition. Gastroenterology 121 (2001) 966-969
74. Sax H.C., and Souba W.W. Enteral and parenteral feedings. Guidelines and recommendations. Med Clin North Am 77 4 (1993) 863-880
75. ASPEN Board of Directors, Clinical Guidelines Task Force. Nutrition assessment-adults. J Parenter Enteral Nutr 26 (2002) 9SA-12SA
76. Baldwin C., and Parsons T.J. Dietary advice and nutritional supplements in the management of illness-related malnutrition: systematic review. Clin Nutr 23 6 (2004) 1267-1279
77. Bozzetti F. Effects of artificial nutrition on the nutritional status of cancer patients. J Parenter Enteral Nutr 13 4 (1989) 406-420
78. Lindh A., Cedermark B., Blomgren H., Wassermann J., and Petrini B. Enteral and parenteral nutrition in anorectic patients with advanced gastrointestinal cancer. J Surg Oncol 33 (1986) 61-65
79. Campos A.C., Butters M., and Meguid M.M. Home enteral nutrition via gastrostomy in advanced head and neck cancer patients. Head Neck 12 2 (1990) 137-142
80. Ovesen L., and Allingstrup L. Different quantities of two commercial liquid diets consumed by weigh-losing cancer patients. J Parenter Enteral Nutr 16 3 (1992) 275-278
81. Fearon K.C., von Meyenfeldt M.F., Moses A.G., et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52 10 (2003) 1479-1486
82. Lee J.H., Machtay M., Unger L.D., et al. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg 124 (1998) 871-875
83. Bozzetti F., Cozzaglio L., Gavazzi C., et al. Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survival. Tumori 84 6 (1998) 681-686
84. Fietkau R., Iro H., Sailer D., and Sauer R. Percutaneous endoscopically guided gastrostomy in patients with head and neck cancer. Rec Res Cancer Res 121 (1991) 269-282
85. Isenring E.A., Capra S., and Bauer J.D. Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer 91 3 (2004) 447-452
86. Shaw J.H. Influence of stress, depletion, and/or malignant disease on the responsiveness of surgical patients to total parenteral nutrition. Am J Clin Nutr 48 1 (1988) 144-147
87. Douglas R.G., and Shaw J.H. Metabolic effects of cancer. Br J Surg 77 3 (1990) 246-254
88. Rabeneck L., McCullough L.B., and Wray N.P. Ethically justified, clinically comprehensive guidelines for percutaneous endoscopic gastrostomy tube placement. Lancet 349 (1997) 496-498
89. Löser C., and Müller M.J. Ethische Richtlinien zur Anlage einer perkutan endoskopischen Gastrostomie (PEG-Sonde). Zschr Gastroenterol 36 (1998) 475-478
90. Ottery F.D., Walsh D., and Strawford A. Pharmacologic management of anorexia/cachexia. Sem Oncol 25 Suppl. 6 (1998) 35-44
91. Strang P. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (Review). Anticaner Res 17 (1997) 657-662
92. Simons J.P.F.H.A., Schols A.M., Hoefnagels J.M.J., Westerterp K.R., ten Velde G.P.M., and Wouters E.F. Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer. Cancer 82 3 (1998) 553-560
93. McMillan D.C., Simpson J.M., Preston T., et al. Effect of megestrol acetate on weight loss, body composition and blood screen of gastrointestinal cancer patients. Clin Nutr 13 (1994) 85-89
94. Fietkau R., Riepl M., Kettner H., Hinke A., and Sauer R. Supportive Behandlung mit Megestrolacetat während der Radio-(Chemo-)Therapie bei Patienten mit Tumoren im Kopf-Hals-Bereich. Strahlentherapie und Onkologie 172 3 (1996) 162-168
95. Bruera E., Macmillan K., Kuehn N., Hanson J., and MacDonald R.N. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer 66 6 (1990) 1279-1282
96. Maltoni M., Nanni O., Scarpi E., Rossi D., Serra P., and Amadori D. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. Ann Oncol 12 (2001) 289-300
97. Pascual L.A., Figuls M., Urrutia C.G., et al. Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome. J Pain Symptom Manage 27 4 (2004) 360-369
98. Yamashita J.I., and Ogawa M. Medroxyprogesterone acetate and cancer cachexia: interleukin-6 involvement. Breast Cancer 7 2 (2000) 130-135
99. Yeh S.S., Wu S.Y., Levine D.M., et al. The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients. J Gerontol A Biol Sci Med Sci 56 1 (2001) M48-M54
100. Loprinzi C.L., Kugler J.W., Sloan J.A., et al. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol 17 (1999) 3299-3306
101. Calder P.C. Fatty acid metabolism and eicosanoid synthesis. Clin Nutr 20 Suppl. 4 (2001) 1-5
102. Takatsuka H., Takemoto Y., Iwata N., et al. Oral eicosapentaenoic acid for complications of bone marrow transplantation. Bone Marrow Transplant 28 8 (2001) 769-774
103. Jatoi A., Rowland K., Loprinzi C.L., et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 22 12 (2004) 2469-2476
104. Bruera E., Strasser F., Palmer J.L., et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol 21 1 (2003) 129-134
105. Burns C.P., Halabi S., Clamon G., et al. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia. Cancer 101 2 (2004) 370-378
106. Persson C., Glimelius B., Ronnelid J., and Nygren P. Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study. Nutrition 21 2 (2005) 170-178
107. Thiel H.J., Fietkau R., and Sauer R. Malnutrition and the role of nutritional support for radiation therapy patients. Rec Res Cancer Res 108 (1988) 205-226
108. Collins M.M., Wight R.G., and Partridge G. Nutritional consequences of radiotherapy in early laryngeal carcinoma. Ann Royal Coll Surg 81 6 (1999) 376-381
109. Huang E.Y., Leung S.W., Wang C.J., et al. Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial. Int J Radiat Oncol Biol Phys 46 3 (2000) 535-539
110. Elia M., van Bokhorst-de van der Schueren M.A.E., Garvey J., et al. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol 28 1 (2006) 5-23
111. Nayel H., el-Ghoneimy E., and el-Haddad S. Impact of nutritional supplementation on treatment delay and morbidity in patients wih head and neck tumors treated with irradiation. Nutrition 8 1 (1992) 13-18
112. Marcy P.Y., Magné N., Bensadoun R.J., et al. Systematic percutaneous fluoroscopic gastrostomy for concomitant radiochemotherapy of advanced head and neck cancer: optimization of therapy. Supp Care Cancer 8 (2000) 410-413
113. Tyldesley S., Sheehan F., Munk P., et al. The use of radiologically placed gastrostomy tubes in head and neck cancer patients receiving radiotherapy. Int J Radiat Oncol Biol Phys 36 5 (1996) 1205-1209
114. Öhrn K.E.O., Wahlin Y.B., and Sjöden P.O. Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications. Supp Care Cancer 9 (2001) 247-257
115. Mekhail T.M., Adelstein D.J., Rybicki L.A., Larto M.A., Saxton J.P., and Lavertu P. Enteral nutrition during the treatment of head and neck carcinoma. Cancer 91 (2001) 1785-1790
116. Lees J. Nasogastric and percutaneous endoscopic gastrostomy feeding in head and neck cancer patients receiving radiotherapy treatment at a regional oncology unit: a two year study. Eur J Cancer Care 6 1 (1997) 45-49
117. Roberge C., Tran M., Massoud C., et al. Quality of life and home enteral tube feeding: a French prospective study in patients with head and neck or oesophageal cancer. Br J Cancer 82 2 (2000) 263-269
118. Klein S., and Koretz R.L. Nutrition support in patients with cancer: What do the data really show?. Nutr Clin Pract 9 (1994) 91-100
119. Weisdorf S.A., Lysne J., Wind D., et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation 43 6 (1987) 833-838
120. Herrmann V.M., and Petruska P.J. Nutrition support in bone marrow transplant recipients. Nutr Clin Pract 8 1 (1993) 19-27
121. Muscaritoli M., Grieco G., Capria S., Iori A.P., and Rossi F.F. Nutritional and metabolic support in patients undergoing bone marrow transplantation. Am J Clin Nutr 75 2 (2002) 183-190
122. Szeluga D.J., Stuart R.K., Brookmeyer R., Utermohlen V., and Santos G.W. Nutritional support of bone marrow transplant recipients: a prospective, randomised clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 47 12 (1987) 3309-3316
123. Roberts S.R., and Miller J.E. Success using PEG tubes in marrow transplant recipients. Nutr Clin Pract 13 (1998) 74-78
124. Hopman G.D., Pena E.G., Le Cessie S., Van Weel M.H., Vossen J.M., and Mearin M.L. Tube feeding and bone marrow transplantation. Med Pediatr Oncol 40 6 (2003) 375-379
125. Anderson P.M., Ramsay N.K., Shu X.O., et al. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant 22 4 (1998) 339-344
126. Schloerb P.R., and Skikne B.S. Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study. J Parenter Enteral Nutr 23 3 (1999) 117-122
127. Coghlin Dickson T.M., Wong R.M., Offrin R.S., et al. Effect of oral glutamine supplementation during bone marrow transplantation. J Parenter Enteral Nutr 24 2 (2000) 61-66
128. Jebb S.A., Marcus R., and Elia M. A pilot study of oral glutamine supplementation in patients receiving bone marrow transplant. Clin Nutr 14 (1995) 162-165
129. Glutamitaly 2003: SINPE consensus paper on the use of glutamine in adult artificial nutrition. RINPE 2004;22(3):115-33.
130. Bozzetti F. Home total parenteral nutrition in incurable cancer patients: a therapy, a basic humane care or something in between?. Clin Nutr 22 2 (2003) 109-111
131. Jonkers-Schuitema C.F. HPN=Home palliative care?. Clin Nutr 23 6 (2004) 1253-1255
132. McCann R.M., Hall W.J., and Groth-Juncker A. Comfort care for terminally ill patients. The appropriate use of nutrition and hydration. J Am Med Assoc 272 16 (1994) 1263-1266
133. Bruera E., Belzile M., Watanabe S., and Fainsinger R.L. Volume of hydration in terminal cancer patients. Support Care Cancer 4 2 (1996) 147-150
134. Martinez-Riquelme A., Rawlings J., Morley S., Kendall J., Hosking D., and Allison S. Self-administered subcutaneous fluid infusion at home in the management of fluid depletion and hypomagnesaemia in gastro-intestinal disease. Clin Nutr 24 1 (2005) 158-163
135. Fainsinger R.L., and Bruera E. When to treat dehydration in a terminally ill patient?. Support Care Cancer 5 3 (1997) 205-211
136. Cao W., Lin Y., and Yin H. Use of parenteral nutritional support in patients with gastric cancer: the relationship of protein turn over, immunocompetence and tumor cell kinetics. Zhonghua Wai Ke Za Zhi 33 5 (1995) 265-268
137. Westin T., Stein H., Niedobitek G., Lundholm K., and Edstrom S. Tumor cytokinetic response to total parenteral nutrition in patients with head and neck cancers. Am J Clin Nutr 53 3 (1991) 764-768
138. Rossi Fanelli F., Franchi F., Mulieri M., et al. Effect of energy substrate manipulation on tumour cell proliferation in parenterally fed cancer patients. Clin Nutr 10 (1991) 228-232
139. McNurlan M.A., Heys S.D., Park K.G., et al. Tumour and host tissue responses to branched-chain amino acid supplementation of patients with cancer. Clin Sci (London) 86 3 (1994) 339-345
140. Ota D.M., Nishioka K., Grossie B., and Dixon D. Erythrocyte polyamine levels during intravenous feeding of patients with colorectal carcinoma. Eur J Cancer Clin Oncol 22 7 (1986) 837-842
141. Baron P.L., Lawrence Jr. W., Chan W.M., White F.K., and Banks Jr. W.L. Effects of parenteral nutrition on cell cycle kinetics of head and neck cancer. Arch Surg 121 11 (1986) 1282-1286
142. Bozzetti F., Gavazzi C., Cozzaglio L., Costa A., Spinelli P., and Viola G. Total parenteral nutrition and tumor growth in malnourished patients with gastric cancer. Tumori 85 3 (1999) 163-166
143. Bozzetti F., Gavazzi C., Mariani L., and Crippa F. Glucose-based total parenteral nutrition does not stimulate glucose uptake by humans tumours. Clin Nutr 23 3 (2004) 417-421
144. Schütz T., Herbst B., and Koller M. Methodology for the development of the ESPEN Guidelines on Enteral Nutrition. Clin Nutr 25 2 (2006) 203-209
145. Lochs H, Allison SP, Meier R, Pirlich M, Kondrup J, Schneider St., van den Berghe G, Pichard C. Introductory to the ESPEN Guidelines on Enteral Nutrition: Terminology, Definitions and General Topics. Clin Nutr 25(2): 180-6.
146. Weimann A., Braga M., Harsanyi L., Laviano A., Ljungqvist O., and Soeters P. ESPEN Guidelines on Enteral Nutrition: Surgery incl. Organ Transplantation. Clin Nutr 25 2 (2006) 224-244